Kuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to Contact Law Firm

Group 1 - Kuehn Law is investigating potential claims related to proposed mergers involving several companies, focusing on whether the boards acted to maximize shareholder value and disclosed material information [1] - Alpine Immune Sciences, Inc. is set to be acquired by Vertex Pharmaceuticals Incorporated, with shareholders receiving $65.00 per share [1] - JBT Corporation has entered into a merger agreement with Marel hf., offering Marel shareholders options for compensation in cash or JBT common stock [1] Group 2 - Eliem Therapeutics, Inc. has agreed to acquire Tenet Medicines Inc., with Tenet's shareholders receiving new shares representing 15.4% of Eliem's common stock post-transaction [2] - HireRight Holdings Corporation will merge with affiliates of General Atlantic, L.P. and Stope Point Capital LLC for $14.35 per share in cash [2]